On-Site Drug Testing Abo, NM
Time is money, we can come to you. Accredited Drug Testing provides on-site drug testing services in Abo, NM and throughout the local area for employers who need drug or alcohol testing at their place of business or other location. On-site drug testing methods include urine drug testing, hair drug testing, oral saliva drug testing and breath alcohol testing. Both instant drug test results and laboratory analyzed testing is available. Testing purposes can include pre-employment, random, reasonable suspicion and post-accident.
Drug Test Screening Panels Available In Abo, NM
We offer a 5-panel drug test, which screens for the following:
- Amphetamines
- Cocaine
- Marijuana
- Opiates
- PCP
We offer a 10-panel drug test which screens for the following:
- Amphetamines
- Barbituates
- Benzodiazepines
- cocaine
- Marijuana
- MDA
- Methadone
- Methaqualone
- Opiates
- PCP
- Propoxyphene
We offer a 12-panel drug test which screens for the following:
- Amphetamines
- Barbiturates
- Benzodiazepines
- cocaine
- Marijuana
- MDA
- Methadone
- Methaqualone
- Opiates
- PCP
- Propoxyphene
- Meperidine
- Tramadol
** Customized drug testing panels such as bath salts, synthetic marijuana, steroids and other drugs are also available.
Urine or Hair On-site Drug Testing In Abo, NM - You Choose!
Our on-site drug testing services in Abo, NM include urine drug testing, which has a detection period of 1-5 days and hair drug testing which has a detection period of up to 90 days. Negative test results are generally available in 24-48 hours, when analyzed by our SAMHSA Certified Laboratories. Negative instant test results are available immediately, non-negative test results require laboratory confirmation.
Why Use On-Site Drug Testing in Abo, NM?
Time is money and when sending an employee to one of our many drug testing centers in Abo, NM would cause disruption to your business operations or affect your employees work productivity, conducting on-site drug testing will eliminate these issues.
Who Uses On-Site Drug Testing?
- Construction Sites
- Manufacturing Plants
- Power Plants
- Motor Pool Facilities
- Car Dealerships
- Trucking/Transportation Companies
- Schools
- Sports Venues
- Hospitals
- Oil & Gas Drillings Sites
Are you a DOT Regulated Company?
Accredited Drug Testing has trained and qualified collectors who also specialize in providing on-site drug testing services for all DOT modes to include:
- Trucking Industry-FMCSA
- Maritime Industry-USCG
- Aviation Industry-FAA
- Public Transportation-FTA
- Railroad Industry-FRA
- Pipeline Industry-PHMSA
Additional DOT Services:
- DOT Consortium Enrollment
- DOT Physicals
- Supervisor Training
- DOT Drug Policy Development
- MVR Reports
- Employee Training
- Background Checks
- FMCSA Clearinghouse Verification/Search
How To Schedule On-Site Drug Testing In Abo, NM?
Step 1 - Call our on-site coordinator at (800)221-4291
Step 2 - Have at least 10 employees needing to be tested (recommended)
Step 3 - Provide the date, location and time of the requested on-site drug testing services
In addition to on-site drug testing in Abo, NM, we also have drug testing centers available at the following locations.
Were you looking, instead, for:
Local Area Info: ABO (gene)
Histo-blood group ABO system transferase is an enzyme with glycosyltransferase activity, which is encoded by the ABO gene in humans. It is ubiquitously expressed in many tissues and cell types. ABO determines the ABO blood group of an individual by modifying the oligosaccharides on cell surface glycoproteins. Variations in the sequence of the protein between individuals determine the type of modification and the blood group. The ABO gene also contains one of 27 SNPs associated with increased risk of coronary artery disease.
The ABO gene resides on chromosome 9 at the band 9q34.2 and contains 7 exons. The ABO locus encodes three alleles. The A allele produces ?-1,3-N-acetylgalactosamine transferase (A-transferase), which catalyzes the transfer of GalNAc residues from the UDP-GalNAc donor nucleotide to the Gal residues of the acceptor H antigen, converting the H antigen into A antigen in A and AB individuals. The B allele encodes ?-1,3-galactosyl transferase (B-transferase), which catalyzes the transfer of Gal residues from the UDP-Gal donor nucleotide to the Gal residues of the acceptor H antigen, converting the H antigen into B antigen in B and AB individuals. Remarkably, the difference between the A and B glycosyltransferase enzymes is only four amino acids. The O allele lacks both enzymatic activities because of the frame shift caused by a deletion of guanine-258 in the gene which corresponds to a region near the N-terminus of the protein.This results in a frameshift and translation of an almost entirely different protein. This mutation results in a protein unable to modify oligosaccharides which end in fucose linked to galactose. Thus no A or B antigen is found in O individuals. This sugar combination is termed the H antigen. These antigens play an important role in the match of blood transfusion and organ transplantation. Other minor alleles have been found for this gene.
In human cells, the ABO alleles and their encoded glycosyltransferases have been described in several oncologic conditions. Using anti-GTA/GTB monoclonal antibodies, it was demonstrated that a loss of these enzymes was correlated to malignant bladder and oral epithelia. Furthermore, the expression of ABO blood group antigens in normal human tissues is dependent the type of differentiation of the epithelium. In most human carcinomas, including oral carcinoma, a significant event as part of the underlying mechanism is decreased expression of the A and B antigens. Several studies have observed that a relative down-regulation of GTA and GTB occurs in oral carcinomas in association with tumor development. More recently, a genome wide association study (GWAS) has identified variants in the ABO locus associated with susceptibility to pancreatic cancer.